Press Releases
-
-
Feb 2, 2021
NLS Pharmaceutics Ltd. Announces Closing of $20.0 Million Initial Public Offering -
Jan 28, 2021
NLS Pharmaceutics Ltd. Announces Pricing of $20.0 Million Initial Public Offering -
Jan 21, 2021
NLS Pharmaceutics Ltd. Announces Notice of Allowance of a new Technology Patent Covering Attention Deficit Hyperactivity Disorder & Narcolepsy
Recent Comments